According to a new market research study titled 'Vaccines Market to 2027, COVID-19 Impact and Global Analysis by Technology, Disease Indication, Route of Administration, Patient Type, and Geography.' The global vaccines market is expected to reach US$ 64,538.4 Mn in 2027 from US$ 39,128.3 Mn in 2019. The market is estimated to grow with a CAGR of 6.5% from 2020-2027. The report highlights the trends prevalent in the global vaccines market and the factors driving the market along with those that act as deterrents to its growth.
The vaccines market by technology is segmented into Recombinant vaccines, Conjugate Vaccines, Live Attenuated Vaccines, Inactivated Vaccines, and Toxoid Vaccines. In 2019, the conjugate vaccines segment held a largest market share in the vaccines market, By Technology. This segment is also expected to dominate the market in 2027 as they are the most effective forms of immunization, used to prevent diseases in both infants and adults. Moreover, the similar segment is anticipated to also witness the fastest growth rate of 6.3% during the forecast period, 2020 to 2027 owing to the increasing demand for drugs to treat the disease.
Driving factors such as , growing focus on immunization programs, increasing support for vaccine development, rising prevalence of infectious diseases. However, the complexity and cost of vaccine manufacturing and soaring costs of vaccines are likely to pose a negative impact on the market growth. On the other hand, robust pipeline of vaccines is likely to have a positive impact on the growth of the global vaccines market in the coming years.
The emergence of coronavirus pandemic is estimated to have significant impact on the vaccines market. Majority of the pharmaceutical companies around the globe are engaged in the development of vaccine for coronavirus. However, this shift of focus for research and development is anticipated to have negative impact on the other segments of the market. Also, the disruptions in supply chain caused due to shut down of global operations are also projected to have adverse impact on the market by certain extent.
Some of the prominent players operating in vaccines market are PFIZER INC, GlaxoSmithKline plc, Merck & Co.Inc. Sanofi, Johnson & Johnson Services, Inc, Panacea Biotec Limited, Astellas Pharma Inc. NOVAVAX, INC.VBI Vaccines Inc, and Bavarian Nordic. The market players are focused towards bringing new and innovative products and services to sustain their position in the market. For instance, in December, 2018, The European Commission has granted marketing authorization for Dengvaxia, Sanofi’s dengue vaccine. The marketing authorization follows the October 18,2018, recommendation by the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) to approve use of the dengue vaccine in European endemic areas. The developments performed by the companies are helping the market to grow in the coming years.
The report segments the global vaccines market as follows:
Global Vaccines Market By Technology
Global Vaccines Market By Route of Administration
Global Vaccines Market By Geography
North America
Europe
Asia Pacific (APAC)
Middle East & Africa (MEA)
South & Central America (SCAM)
Reasons to Buy
The vaccines market by technology is segmented into Recombinant vaccines, Conjugate Vaccines, Live Attenuated Vaccines, Inactivated Vaccines, and Toxoid Vaccines. In 2019, the conjugate vaccines segment held a largest market share in the vaccines market, By Technology. This segment is also expected to dominate the market in 2027 as they are the most effective forms of immunization, used to prevent diseases in both infants and adults. Moreover, the similar segment is anticipated to also witness the fastest growth rate of 6.3% during the forecast period, 2020 to 2027 owing to the increasing demand for drugs to treat the disease.
Driving factors such as , growing focus on immunization programs, increasing support for vaccine development, rising prevalence of infectious diseases. However, the complexity and cost of vaccine manufacturing and soaring costs of vaccines are likely to pose a negative impact on the market growth. On the other hand, robust pipeline of vaccines is likely to have a positive impact on the growth of the global vaccines market in the coming years.
The emergence of coronavirus pandemic is estimated to have significant impact on the vaccines market. Majority of the pharmaceutical companies around the globe are engaged in the development of vaccine for coronavirus. However, this shift of focus for research and development is anticipated to have negative impact on the other segments of the market. Also, the disruptions in supply chain caused due to shut down of global operations are also projected to have adverse impact on the market by certain extent.
Some of the prominent players operating in vaccines market are PFIZER INC, GlaxoSmithKline plc, Merck & Co.Inc. Sanofi, Johnson & Johnson Services, Inc, Panacea Biotec Limited, Astellas Pharma Inc. NOVAVAX, INC.VBI Vaccines Inc, and Bavarian Nordic. The market players are focused towards bringing new and innovative products and services to sustain their position in the market. For instance, in December, 2018, The European Commission has granted marketing authorization for Dengvaxia, Sanofi’s dengue vaccine. The marketing authorization follows the October 18,2018, recommendation by the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) to approve use of the dengue vaccine in European endemic areas. The developments performed by the companies are helping the market to grow in the coming years.
The report segments the global vaccines market as follows:
Global Vaccines Market By Technology
- Recombinant vaccines
- Conjugate Vaccines
- Live Attenuated Vaccines
- Inactivated Vaccines
- Toxoid Vaccines
- Global Vaccines Market By Disease Indication
- DTP (diphtheria, tetanus, and pertussis)
- Influenza
- Hepatitis
- Dengue
- Cytomegalovirus (CMV)
- Respiratory Syncytial Virus (RSV)
- Other Diseases
Global Vaccines Market By Route of Administration
- Oral
- Injectable
- Other
- Global Vaccines Market By Patient Type
- Adult Patients
- Pediatric Patients
Global Vaccines Market By Geography
North America
- U. S.
- Canada
- Mexico
Europe
- U. K.
- Germany
- France
- Italy
- Spain
Asia Pacific (APAC)
- Japan
- China
- India
- Australia
- South Korea
Middle East & Africa (MEA)
- South Africa
- UAE
- Saudi Arabia
South & Central America (SCAM)
- Brazil
- Argentina
Reasons to Buy
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the vaccines market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the global vaccines market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution
Table of Contents
1. Introduction1.1 Scope Of The Study
1.2 Report Guidance
1.3 Market Segmentation
1.3.1 Global Vaccines Market - By Technology
1.3.2 Global Vaccines Market - By Disease Indication
1.3.3 Global Vaccines Market - By Route of Administration
1.3.4 Global Vaccines Market - By Patient Type
1.3.5 Global Vaccines Market - By Geography
2. Vaccines Market - Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Global Vaccines Market - Market Landscape
4.1 Overview
4.2 Pest Analysis
4.2.1 North America - PEST Analysis
4.2.2 Europe- PEST Analysis
4.2.3 Asia Pacific- PEST Analysis
4.2.4 Middle East & Africa- PEST Analysis
4.2.5 South and Central America - PEST Analysis
4.3 Expert Opinions
5. Global Vaccines Market - Key Market Dynamics
5.1 Key Market Drivers
5.1.1 Rising Prevalence of Infectious Diseases
5.1.2 Growing Focus on Immunization Programs
5.1.3 Increasing Support for Vaccine Development
5.2 Key Market Restraints
5.2.1 The Complexity And Cost of Vaccine Manufacturing
5.2.2 Soaring Costs of Vaccines
5.3 Key Market Opportunities
5.3.1 Robust Pipeline of Vaccines
5.4 Future Trends
5.4.1 New Vaccine Delivery Systems
5.5 Impact Analysis
6. Vaccines Market - Global Analysis
6.1 Global Vaccines Market Revenue Forecasts And Analysis
6.2 Global Vaccines Market, By Geography - Forecasts And Analysis
6.3 Performance Of Key Players
6.3.1 GlaxoSmithKline plc
6.3.2 Sanofi
7. Vaccines Market - Technology
7.1 Overview
7.2 Vaccines Market Share, Technology, 2019 And 2027 (%)
7.3 Recombinant Vaccinesinant Vaccines
7.3.1 Overview
7.3.2 Recombinant Vaccinesinant Vaccines: Vaccines Market- Revenue and Forecast to 2027 (US$ Million)
7.4 Conjugate Vaccines
7.4.1 Overview
7.4.2 Conjugate Vaccines: Vaccines Market- Revenue and Forecast to 2027 (US$ Million)
7.5 Live Attenuated Vaccines Attenuated Vaccines
7.5.1 Overview
7.5.2 Live Attenuated Vaccines Attenuated Vaccines: Vaccines Market- Revenue and Forecast to 2027 (US$ Million)
7.6 Inactivated and Subunit Vaccines Vaccines
7.6.1 Overview
7.6.2 Inactivated and Subunit Vaccines Vaccines: Vaccines Market- Revenue and Forecast to 2027 (US$ Million)
7.7 Toxoid Vaccines Vaccines
7.7.1 Overview
7.7.2 Toxoid Vaccines Vaccines: Vaccines Market- Revenue and Forecast to 2027 (US$ Million)
8. Vaccines Market- Disease Indication
8.1 Overview
8.2 Disease Indication Market Revenue And Forecasts Analysis (Us$ Mn)
8.3 Dtp (Diphtheria, Tetanus, And Pertussis)
8.3.1 Overview
8.3.2 DTP (Diphtheria, Tetanus, And Pertussis): Vaccines Market- Revenue and Forecast to 2027 (US$ Million)
8.4 Influenza
8.4.1 Overview
8.4.2 Influenza: Vaccines Market -Revenue and Forecast to 2027 (US$ Million)
8.5 Dengue
8.5.1 Overview
8.5.2 Dengue: Vaccines Market- Revenue and Forecast to 2027 (US$ Million)
8.6 Cytomegalovirus (CMV)
8.6.1 Overview
8.6.2 Cytomegalovirus (CMV): Vaccines Market -Revenue and Forecast to 2027 (US$ Million)
8.7 Hepatitis
8.7.1 Overview
8.7.2 Hepatitis: Vaccines Market - Revenue and Forecast to 2027 (US$ Million)
8.7.3 Hepatitis A
8.7.3.1 Overview
8.7.3.2 Hepatitis A: Hepatitis Market - Revenue and Forecast to 2027 (US$ Million)
8.7.4 Hepatitis B
8.7.4.1 Overview
8.7.4.2 Hepatitis B: Vaccines Market - Revenue and Forecast to 2027 (US$ Million)
8.8 Respiratory Syncytial Virus (Rsv)
8.8.1 Overview
8.8.2 Respiratory Syncytial Virus (RSV): Vaccines Market - Revenue and Forecast to 2027 (US$ Million)
8.9 Other Diseases
8.9.1 Overview
8.9.2 Other Diseases: Vaccines Market -Revenue and Forecast to 2027 (US$ Million)
9. Vaccines Market- Route Of Administration
9.1 Overview
9.2 Route Of Administration Market Revenue And Forecasts Analysis (Us$ Mn)
9.3 Oral
9.3.1 Overview
9.3.2 Oral: Vaccines Market - Revenue and Forecast to 2027 (US$ Million)
9.4 Injectable
9.4.1 Overview
9.4.2 Injectable: Vaccines Market -Revenue and Forecast to 2027 (US$ Million)
9.5 Other Routes Of Administrations
9.5.1 Overview
9.5.2 Other Routes of Administration; Vaccines Market - Revenue and Forecast to 2027 (US$ Million)
10. Vaccines Market- Patient Type
10.1 Overview
10.2 Patient Type Market Revenue And Forecasts Analysis (Us$ Mn)
10.3 Paediatric
10.3.1 Overview
10.3.2 Pediatric: Vaccines Market - Revenue and Forecast to 2027 (US$ Million)
10.4 Adults Market
10.4.1 Overview
10.4.2 Adults: Vaccines Market - Revenue and Forecast to 2027 (US$ Million)
11. Vaccines Market- Geographical Analysis
11.1 North America: Vaccines Market
11.1.1 Overview
11.1.2 North America: Vaccines Market- Revenue And Forecasts to 2027 (USD Million)
11.1.3 North America: Vaccines Market, By Technology, 2018-2027 (USD Million)
11.1.4 North America: Vaccines Market, By Disease Indication, 2018-2027 (USD Million)
11.1.4.1 North America: Vaccines Market, By Hepatitis, 2018-2027 (USD Million)
11.1.5 North America: Vaccines Market, By Route of Administration, 2018-2027 (USD Million)
11.1.6 North America: Vaccines Market, By Patient Type, 2018-2027 (USD Million)
11.1.7 North America: Vaccines Market, By Country, 2019 & 2027 (%)
11.1.8 US Vaccines Market Revenue and Forecasts to 2027 (US$ Mn)
11.1.8.1 US: Vaccines Market, By Technology, 2018-2027 (USD Million)
11.1.8.2 US: Vaccines Market, By Disease Indication, 2018-2027 (USD Million)
11.1.8.2.1 US: Vaccines Market, By Hepatitis, 2018-2027 (USD Million)
11.1.8.3 US: Vaccines Market, By Route of Administration, 2018-2027 (USD Million)
11.1.8.4 US: Vaccines Market, By Patient Type, 2018-2027 (USD Million)
11.1.9 Canada Vaccines Market Revenue and Forecasts to 2027 (US$ Mn)
11.1.9.1 Canada: Vaccines Market- Revenue And Forecasts to 2027 (USD Million)
11.1.9.2 Canada: Vaccines Market, By Technology, 2018-2027 (USD Million)
11.1.9.3 Canada: Vaccines Market, By Disease Indication, 2018-2027 (USD Million)
11.1.9.3.1 Canada: Vaccines Market, By Hepatitis, 2018-2027 (USD Million)
11.1.9.4 Canada: Vaccines Market, By Route of Administration, 2018-2027 (USD Million)
11.1.9.5 Canada: Vaccines Market, By Patient Type, 2018-2027 (USD Million)
11.1.10 Mexico Vaccines Market Revenue and Forecasts to 2027 (US$ Mn)
11.1.10.1 Mexico: Vaccines Market- Revenue And Forecasts to 2027 (USD Million)
11.1.10.2 Mexico: Vaccines Market, By Technology, 2018-2027 (USD Million)
11.1.10.3 Mexico: Vaccines Market, By Disease Indication, 2018-2027 (USD Million)
11.1.10.3.1 Mexico: Vaccines Market, By Hepatitis, 2018-2027 (USD Million)
11.1.10.4 Mexico: Vaccines Market, By Route of Administration, 2018-2027 (USD Million)
11.1.10.5 Mexico: Vaccines Market, By Patient Type, 2018-2027 (USD Million)
11.2 Europe: Vaccines Market
11.2.1 Overview
11.2.2 Europe: Vaccines Market Revenue, by Country (2019) (US$ Mn)
11.2.3 Europe: Vaccines Market- Revenue And Forecasts to 2027 (USD Million)
11.2.4 Europe: Vaccines Market, By Technology, 2018-2027 (USD Million)
11.2.5 Europe: Vaccines Market, By Disease Indication, 2018-2027 (USD Million)
11.2.5.1 Europe: Vaccines Market, By Hepatitis, 2018-2027 (USD Million)
11.2.6 Europe: Vaccines Market, By Route of Administration, 2018-2027 (USD Million)
11.2.7 Europe: Vaccines Market, By Patient Type, 2018-2027 (USD Million)
11.2.8 Europe: Vaccines Market, By Country, 2019 & 2027 (%)
11.2.9 Germany Vaccines Market Revenue and Forecasts to 2027 (US$ Mn)
11.2.9.1 Germany: Vaccines Market- Revenue And Forecasts to 2027 (USD Million)
11.2.9.2 Germany: Vaccines Market, By Technology, 2018-2027 (USD Million)
11.2.9.3 Germany: Vaccines Market, By Disease Indication, 2018-2027 (USD Million)
11.2.9.3.1 Germany: Vaccines Market, By Hepatitis, 2018-2027 (USD Million)
11.2.9.4 Germany: Vaccines Market, By Route of Administration, 2018-2027 (USD Million)
11.2.9.5 Germany: Vaccines Market, By Patient Type, 2018-2027 (USD Million)
11.2.10 UK Vaccines Market Revenue and Forecasts to 2027 (US$ Mn)
11.2.10.1 UK: Vaccines Market- Revenue And Forecasts to 2027 (USD Million)
11.2.10.2 UK: Vaccines Market, By Technology, 2018-2027 (USD Million)
11.2.10.3 UK: Vaccines Market, By Disease Indication, 2018-2027 (USD Million)
11.2.10.3.1 UK: Vaccines Market, By Hepatitis, 2018-2027 (USD Million)
11.2.10.4 UK: Vaccines Market, By Route of Administration, 2018-2027 (USD Million)
11.2.10.5 UK: Vaccines Market, By Patient Type, 2018-2027 (USD Million)
11.2.11 France Vaccines Market Revenue and Forecasts to 2027 (US$ Mn)
11.2.11.1 France: Vaccines Market- Revenue And Forecasts to 2027 (USD Million)
11.2.11.2 France: Vaccines Market, By Technology, 2018-2027 (USD Million)
11.2.11.3 France: Vaccines Market, By Disease Indication, 2018-2027 (USD Million)
11.2.11.3.1 France: Vaccines Market, By Hepatitis, 2018-2027 (USD Million)
11.2.11.4 France: Vaccines Market, By Route of Administration, 2018-2027 (USD Million)
11.2.11.5 France: Vaccines Market, By Patient Type, 2018-2027 (USD Million)
11.2.12 Italy Vaccines Market Revenue and Forecasts to 2027 (US$ Mn)
11.2.12.1 Italy: Vaccines Market- Revenue And Forecasts to 2027 (USD Million)
11.2.12.2 Italy: Vaccines Market, By Technology, 2018-2027 (USD Million)
11.2.12.3 Italy: Vaccines Market, By Disease Indication, 2018-2027 (USD Million)
11.2.12.3.1 Italy: Vaccines Market, By Hepatitis, 2018-2027 (USD Million)
11.2.12.4 Italy: Vaccines Market, By Route of Administration, 2018-2027 (USD Million)
11.2.12.5 Italy: Vaccines Market, By Patient Type, 2018-2027 (USD Million)
11.2.13 Spain Vaccines Market Revenue and Forecasts to 2027 (US$ Mn)
11.2.13.1 Spain: Vaccines Market- Revenue And Forecasts to 2027 (USD Million)
11.2.13.2 Spain: Vaccines Market, By Technology, 2018-2027 (USD Million)
11.2.13.3 Spain: Vaccines Market, By Disease Indication, 2018-2027 (USD Million)
11.2.13.3.1 Spain: Vaccines Market, By Hepatitis, 2018-2027 (USD Million)
11.2.13.4 Spain: Vaccines Market, By Route of Administration, 2018-2027 (USD Million)
11.2.13.5 Spain: Vaccines Market, By Patient Type, 2018-2027 (USD Million)
11.3 Asia Pacific Vaccines Market
11.3.1 Overview
11.3.2 Asia Pacific: Vaccines Market- Revenue And Forecasts to 2027 (USD Million)
11.3.3 Asia Pacific: Vaccines Market, By Technology, 2018-2027 (USD Million)
11.3.4 Asia Pacific: Vaccines Market, By Disease Indication, 2018-2027 (USD Million)
11.3.4.1 Asia Pacific: Vaccines Market, By Hepatitis, 2018-2027 (USD Million)
11.3.5 Asia Pacific: Vaccines Market, By Route of Administration, 2018-2027 (USD Million)
11.3.6 Asia Pacific: Vaccines Market, By Patient Type, 2018-2027 (USD Million)
11.3.7 Asia Pacific: Vaccines Market, By Country, 2018 & 2027 (%)
11.3.8 China Vaccines Market Revenue and Forecasts to 2027 (US$ Mn)
11.3.8.1 China: Vaccines Market- Revenue And Forecasts to 2027 (USD Million)
11.3.8.2 China: Vaccines Market, By Technology, 2018-2027 (USD Million)
11.3.8.3 China: Vaccines Market, By Disease Indication, 2018-2027 (USD Million)
11.3.8.3.1 China: Vaccines Market, By Hepatitis, 2018-2027 (USD Million)
11.3.8.4 China: Vaccines Market, By Route of Administration, 2018-2027 (USD Million)
11.3.8.5 China: Vaccines Market, By Patient Type, 2018-2027 (USD Million)
11.3.9 Japan Vaccines Market Revenue and Forecasts to 2027 (US$ Mn)
11.3.9.1 Japan: Vaccines Market- Revenue And Forecasts to 2027 (USD Million)
11.3.9.2 Japan: Vaccines Market, By Technology, 2018-2027 (USD Million)
11.3.9.3 Japan: Vaccines Market, By Disease Indication, 2018-2027 (USD Million)
11.3.9.3.1 Japan: Vaccines Market, By Hepatitis, 2018-2027 (USD Million)
11.3.9.4 Japan: Vaccines Market, By Route of Administration, 2018-2027 (USD Million)
11.3.9.5 Japan: Vaccines Market, By Patient Type, 2018-2027 (USD Million)
11.3.10 India Vaccines Market Revenue and Forecasts to 2027 (US$ Mn)
11.3.10.1 India: Vaccines Market- Revenue And Forecasts to 2027 (USD Million)
11.3.10.2 India: Vaccines Market, By Technology, 2018-2027 (USD Million)
11.3.10.3 India: Vaccines Market, By Disease Indication, 2018-2027 (USD Million)
11.3.10.3.1 India: Vaccines Market, By Hepatitis, 2018-2027 (USD Million)
11.3.10.4 India: Vaccines Market, By Route of Administration, 2018-2027 (USD Million)
11.3.10.5 India: Vaccines Market, By Patient Type, 2018-2027 (USD Million)
11.3.11 Australia Vaccines Market Revenue and Forecasts to 2027 (US$ Mn)
11.3.11.1 Australia: Vaccines Market- Revenue And Forecasts to 2027 (USD Million)
11.3.11.2 Australia: Vaccines Market, By Technology, 2018-2027 (USD Million)
11.3.11.3 Australia: Vaccines Market, By Disease Indication, 2018-2027 (USD Million)
11.3.11.3.1 Australia: Vaccines Market, By Hepatitis, 2018-2027 (USD Million)
11.3.11.4 Australia: Vaccines Market, By Route of Administration, 2018-2027 (USD Million)
11.3.11.5 Australia: Vaccines Market, By Patient Type, 2018-2027 (USD Million)
11.3.12 South Korea Vaccines Market Revenue and Forecasts to 2027 (US$ Mn)
11.3.12.1 South Korea: Vaccines Market- Revenue And Forecasts to 2027 (USD Million)
11.3.12.2 South Korea: Vaccines Market, By Technology, 2018-2027 (USD Million)
11.3.12.3 South Korea: Vaccines Market, By Disease Indication, 2018-2027 (USD Million)
11.3.12.3.1 South Korea: Vaccines Market, By Hepatitis, 2018-2027 (USD Million)
11.3.12.4 South Korea: Vaccines Market, By Route of Administration, 2018-2027 (USD Million)
11.3.12.5 South Korea: Vaccines Market, By Patient Type, 2018-2027 (USD Million)
11.4 Middle East & Africa Vaccines Market
11.4.1 Middle East And Africa: Vaccines Market- Revenue And Forecasts to 2027 (USD Million)
11.4.2 Middle East and Africa: Vaccines Market, By Technology, 2018-2027 (USD Million)
11.4.3 Middle East and Africa: Vaccines Market, By Disease Indication, 2018-2027 (USD Million)
11.4.3.1 Middle East and Africa: Vaccines Market, By Hepatitis, 2018-2027 (USD Million)
11.4.4 Middle East and Africa: Vaccines Market, By Route of Administration, 2018-2027 (USD Million)
11.4.5 Middle East and Africa: Vaccines Market, By Patient Type, 2018-2027 (USD Million)
11.4.6 Middle East & Africa: Vaccines Market, By Country, 2019 & 2027 (%)
11.4.7 UAE Vaccines Market Revenue and Forecasts to 2027 (US$ Mn)
11.4.7.1 UAE: Vaccines Market- Revenue And Forecasts to 2027 (USD Million)
11.4.7.2 UAE: Vaccines Market, By Technology, 2018-2027 (USD Million)
11.4.7.3 UAE: Vaccines Market, By Disease Indication, 2018-2027 (USD Million)
11.4.7.3.1 UAE: Vaccines Market, By Hepatitis, 2018-2027 (USD Million)
11.4.7.4 UAE: Vaccines Market, By Route of Administration, 2018-2027 (USD Million)
11.4.7.5 UAE: Vaccines Market, By Patient Type, 2018-2027 (USD Million)
11.4.8 Saudi Arabia Vaccines Market Revenue and Forecasts to 2027 (US$ Mn)
11.4.8.1 Saudi Arabia: Vaccines Market- Revenue And Forecasts to 2027 (USD Million)
11.4.8.2 Saudi Arabia: Vaccines Market, By Technology, 2018-2027 (USD Million)
11.4.8.3 Saudi Arabia: Vaccines Market, By Disease Indication, 2018-2027 (USD Million)
11.4.8.3.1 Saudi Arabia: Vaccines Market, By Hepatitis, 2018-2027 (USD Million)
11.4.8.4 Saudi Arabia: Vaccines Market, By Route of Administration, 2018-2027 (USD Million)
11.4.8.5 Saudi Arabia: Vaccines Market, By Patient Type, 2018-2027 (USD Million)
11.4.9 South Africa Vaccines Market Revenue and Forecasts to 2027 (US$ Mn)
11.4.9.1 South Africa: Vaccines Market- Revenue And Forecasts to 2027 (USD Million)
11.4.9.2 South Africa: Vaccines Market, By Technology, 2018-2027 (USD Million)
11.4.9.3 South Africa: Vaccines Market, By Disease Indication, 2018-2027 (USD Million)
11.4.9.3.1 South Africa: Vaccines Market, By Hepatitis, 2018-2027 (USD Million)
11.4.9.4 South Africa: Vaccines Market, By Route of Administration, 2018-2027 (USD Million)
11.4.9.5 South Africa: Vaccines Market, By Patient Type, 2018-2027 (USD Million)
11.5 South And Central America Vaccines Market
11.5.1 Overview
11.5.2 South and Central America: Vaccines Market- Revenue And Forecasts to 2027 (USD Million)
11.5.3 South and Central America: Vaccines Market, By Technology, 2018-2027 (USD Million)
11.5.4 South and Central America: Vaccines Market, By Disease Indication, 2018-2027 (USD Million)
11.5.4.1 South and Central America: Vaccines Market, By Hepatitis, 2018-2027 (USD Million)
11.5.5 South and Central America: Vaccines Market, By Route of Administration, 2018-2027 (USD Million)
11.5.6 South and Central America: Vaccines Market, By Patient Type, 2018-2027 (USD Million)
11.5.7 South and Central America: Vaccines Market, by Country, 2019 and 2027 (%)
11.5.8 Brazil Vaccines Market Revenue and Forecasts to 2027 (US$ Mn)
11.5.8.1 Brazil: Vaccines Market- Revenue And Forecasts to 2027 (USD Million)
11.5.8.2 Brazil: Vaccines Market, By Technology, 2018-2027 (USD Million)
11.5.8.3 Brazil: Vaccines Market, By Disease Indication, 2018-2027 (USD Million)
11.5.8.3.1 Brazil: Vaccines Market, By Hepatitis, 2018-2027 (USD Million)
11.5.8.4 Brazil: Vaccines Market, By Route of Administration, 2018-2027 (USD Million)
11.5.8.5 Brazil: Vaccines Market, By Patient Type, 2018-2027 (USD Million)
11.5.9 Argentina Vaccines Market Revenue and Forecasts to 2027 (US$ Mn)
11.5.9.1 Argentina: Vaccines Market- Revenue And Forecasts to 2027 (USD Million)
11.5.9.2 Argentina: Vaccines Market, By Technology, 2018-2027 (USD Million)
11.5.9.3 Argentina: Vaccines Market, By Disease Indication, 2018-2027 (USD Million)
11.5.9.3.1 Argentina: Vaccines Market, By Hepatitis, 2018-2027 (USD Million)
11.5.9.4 Argentina: Vaccines Market, By Route of Administration, 2018-2027 (USD Million)
11.5.9.5 Argentina: Vaccines Market, By Patient Type, 2018-2027 (USD Million)
12. Impact Of Covid-19 Pandemic On Global Vaccines Market
12.1 North America: Impact assessment of COVID-19 Pandemic
12.2 Europe: Impact assessment of COVID-19 Pandemic
12.3 Asia-Pacific: Impact assessment of COVID-19 Pandemic
12.4 Rest of World: Impact assessment of COVID-19 Pandemic
13. Vaccines Market - Industry Landscape
13.1 Overview
13.2 Growth Strategies Done By The Companies In The Market, (%)
13.3 Organic Developments
13.3.1 Overview
13.4 Inorganic Developments
13.4.1 Overview
14. Vaccines Market -Key Company Profiles
14.1 Pfizer Inc.
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Financial Overview
14.1.4 Product Portfolio
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 Glaxosmithkline Plc.
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Financial Overview
14.2.4 Product Portfolio
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 Merck & Co., Inc.
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Financial Overview
14.3.4 Product Portfolio
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 Sanofi
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Financial Information
14.4.4 Product Portfolio
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 Johnson & Johnson Services, Inc.
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Financial Overview
14.5.4 Product Portfolio
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 Panacea Biotec Limited
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Financial Information
14.6.4 Product Portfolio
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 Astellas Pharma Inc.
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Financial Overview
14.7.4 Product Portfolio
14.7.5 Swot Analysis
14.7.6 Key Developments
14.8 Novavax, Inc.
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Financial Information
14.8.4 Product Pipeline
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 Vbi Vaccines Inc.
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Financial Information
14.9.4 Product Portfolio
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 Bavarian Nordic
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Financial Information
14.10.4 Product Pipeline
14.10.5 SWOT Analysis
14.10.6 Key Developments
15. Appendix
15.1 About the Publisher
15.2 Glossary Of TermsList of Tables
Table 1. North America Vaccines Market, By Technology - Revenue And Forecast to 2027 (USD Million)
Table 2. North America: Vaccines Market, By Disease Indication - Revenue And Forecasts to 2027 (USD Million)
Table 3. North America: Vaccines Market, By Hepatitis - Revenue And Forecasts to 2027 (USD Million)
Table 4. North America: Vaccines Market, By Route Of Administration - Revenue And Forecasts to 2027 (USD Million)
Table 5. North America: Vaccines Market, By Patient Type - Revenue And Forecasts to 2027 (USD Million)
Table 6. US Vaccines Market, By Technology - Revenue And Forecast to 2027 (USD Million)
Table 7. US: Vaccines Market, By Disease Indication - Revenue And Forecasts to 2027 (USD Million)
Table 8. US: Vaccines Market, By Hepatitis - Revenue And Forecasts to 2027 (USD Million)
Table 9. US: Vaccines Market, By Route Of Administration - Revenue And Forecasts to 2027 (USD Million)
Table 10. US: Vaccines Market, By Patient Type - Revenue And Forecasts to 2027 (USD Million)
Table 11. Canada Vaccines Market, By Technology - Revenue And Forecast to 2027 (USD Million)
Table 12. Canada: Vaccines Market, By Disease Indication - Revenue And Forecasts to 2027 (USD Million)
Table 13. Canada: Vaccines Market, By Hepatitis - Revenue And Forecasts to 2027 (USD Million)
Table 14. Canada: Vaccines Market, By Route Of Administration - Revenue And Forecasts to 2027 (USD Million)
Table 15. Canada: Vaccines Market, By Patient Type - Revenue And Forecasts to 2027 (USD Million)
Table 16. Mexico Vaccines Market, By Technology - Revenue And Forecast to 2027 (USD Million)
Table 17. Mexico: Vaccines Market, By Disease Indication - Revenue And Forecasts to 2027 (USD Million)
Table 18. Mexico: Vaccines Market, By Hepatitis - Revenue And Forecasts to 2027 (USD Million)
Table 19. Mexico: Vaccines Market, By Route Of Administration - Revenue And Forecasts to 2027 (USD Million)
Table 20. Mexico: Vaccines Market, By Patient Type - Revenue And Forecasts to 2027 (USD Million)
Table 21. Europe Vaccines Market, By Technology - Revenue And Forecast to 2027 (USD Million)
Table 22. Europe: Vaccines Market, By Disease Indication - Revenue And Forecasts to 2027 (USD Million)
Table 23. Europe: Vaccines Market, By Hepatitis - Revenue And Forecasts to 2027 (USD Million)
Table 24. Europe: Vaccines Market, By Route Of Administration - Revenue And Forecasts to 2027 (USD Million)
Table 25. Europe: Vaccines Market, By Patient Type - Revenue And Forecasts to 2027 (USD Million)
Table 26. Germany Vaccines Market, By Technology - Revenue And Forecast to 2027 (USD Million)
Table 27. Germany: Vaccines Market, By Disease Indication - Revenue And Forecasts to 2027 (USD Million)
Table 28. Germany: Vaccines Market, By Hepatitis - Revenue And Forecasts to 2027 (USD Million)
Table 29. Germany: Vaccines Market, By Route Of Administration - Revenue And Forecasts to 2027 (USD Million)
Table 30. Germany: Vaccines Market, By Patient Type - Revenue And Forecasts to 2027 (USD Million)
Table 31. UK Vaccines Market, By Technology - Revenue And Forecast to 2027 (USD Million)
Table 32. UK: Vaccines Market, By Disease Indication - Revenue And Forecasts to 2027 (USD Million)
Table 33. UK: Vaccines Market, By Hepatitis - Revenue And Forecasts to 2027 (USD Million)
Table 34. UK: Vaccines Market, By Route Of Administration - Revenue And Forecasts to 2027 (USD Million)
Table 35. UK: Vaccines Market, By Patient Type - Revenue And Forecasts to 2027 (USD Million)
Table 36. France Vaccines Market, By Technology - Revenue And Forecast to 2027 (USD Million)
Table 37. France: Vaccines Market, By Disease Indication - Revenue And Forecasts to 2027 (USD Million)
Table 38. France: Vaccines Market, By Hepatitis - Revenue And Forecasts to 2027 (USD Million)
Table 39. France: Vaccines Market, By Route Of Administration - Revenue And Forecasts to 2027 (USD Million)
Table 40. France: Vaccines Market, By Patient Type - Revenue And Forecasts to 2027 (USD Million)
Table 41. Italy Vaccines Market, By Technology - Revenue And Forecast to 2027 (USD Million)
Table 42. Italy: Vaccines Market, By Disease Indication - Revenue And Forecasts to 2027 (USD Million)
Table 43. Italy: Vaccines Market, By Hepatitis - Revenue And Forecasts to 2027 (USD Million)
Table 44. Italy: Vaccines Market, By Route Of Administration - Revenue And Forecasts to 2027 (USD Million)
Table 45. Italy: Vaccines Market, By Patient Type - Revenue And Forecasts to 2027 (USD Million)
Table 46. Spain Vaccines Market, By Technology - Revenue And Forecast to 2027 (USD Million)
Table 47. Spain: Vaccines Market, By Disease Indication - Revenue And Forecasts to 2027 (USD Million)
Table 48. Spain: Vaccines Market, By Hepatitis - Revenue And Forecasts to 2027 (USD Million)
Table 49. Spain: Vaccines Market, By Route Of Administration - Revenue And Forecasts to 2027 (USD Million)
Table 50. Spain: Vaccines Market, By Patient Type - Revenue And Forecasts to 2027 (USD Million)
Table 51. Asia Pacific Vaccines Market, By Technology - Revenue And Forecast to 2027 (USD Million)
Table 52. Asia Pacific: Vaccines Market, By Disease Indication - Revenue And Forecasts to 2027 (USD Million)
Table 53. Asia Pacific: Vaccines Market, By Hepatitis - Revenue And Forecasts to 2027 (USD Million)
Table 54. Asia Pacific: Vaccines Market, By Route Of Administration - Revenue And Forecasts to 2027 (USD Million)
Table 55. Asia Pacific: Vaccines Market, By Patient Type - Revenue And Forecasts to 2027 (USD Million)
Table 56. China Vaccines Market, By Technology - Revenue And Forecast to 2027 (USD Million)
Table 57. China: Vaccines Market, By Disease Indication - Revenue And Forecasts to 2027 (USD Million)
Table 58. China: Vaccines Market, By Hepatitis - Revenue And Forecasts to 2027 (USD Million)
Table 59. China: Vaccines Market, By Route Of Administration - Revenue And Forecasts to 2027 (USD Million)
Table 60. China: Vaccines Market, By Patient Type - Revenue And Forecasts to 2027 (USD Million)
Table 61. Japan Vaccines Market, By Technology - Revenue And Forecast to 2027 (USD Million)
Table 62. Japan: Vaccines Market, By Disease Indication - Revenue And Forecasts to 2027 (USD Million)
Table 63. Japan: Vaccines Market, By Hepatitis - Revenue And Forecasts to 2027 (USD Million)
Table 64. Japan: Vaccines Market, By Route Of Administration - Revenue And Forecasts to 2027 (USD Million)
Table 65. Japan: Vaccines Market, By Patient Type - Revenue And Forecasts to 2027 (USD Million)
Table 66. India Vaccines Market, By Technology - Revenue And Forecast to 2027 (USD Million)
Table 67. India: Vaccines Market, By Disease Indication - Revenue And Forecasts to 2027 (USD Million)
Table 68. India: Vaccines Market, By Hepatitis - Revenue And Forecasts to 2027 (USD Million)
Table 69. India: Vaccines Market, By Route Of Administration - Revenue And Forecasts to 2027 (USD Million)
Table 70. India: Vaccines Market, By Patient Type - Revenue And Forecasts to 2027 (USD Million)
Table 71. Australia Vaccines Market, By Technology - Revenue And Forecast to 2027 (USD Million)
Table 72. Australia: Vaccines Market, By Disease Indication - Revenue And Forecasts to 2027 (USD Million)
Table 73. Australia: Vaccines Market, By Hepatitis - Revenue And Forecasts to 2027 (USD Million)
Table 74. Australia: Vaccines Market, By Route Of Administration - Revenue And Forecasts to 2027 (USD Million)
Table 75. Australia: Vaccines Market, By Patient Type - Revenue And Forecasts to 2027 (USD Million)
Table 76. South Korea Vaccines Market, By Technology - Revenue And Forecast to 2027 (USD Million)
Table 77. South Korea: Vaccines Market, By Disease Indication - Revenue And Forecasts to 2027 (USD Million)
Table 78. South Korea: Vaccines Market, By Hepatitis - Revenue And Forecasts to 2027 (USD Million)
Table 79. South Korea: Vaccines Market, By Route Of Administration - Revenue And Forecasts to 2027 (USD Million)
Table 80. South Korea: Vaccines Market, By Patient Type - Revenue And Forecasts to 2027 (USD Million)
Table 81. Middle East and Africa Vaccines Market, By Technology - Revenue And Forecast to 2027 (USD Million)
Table 82. Middle East and Africa: Vaccines Market, By Disease Indication - Revenue And Forecasts to 2027 (USD Million)
Table 83. Middle East and Africa: Vaccines Market, By Hepatitis - Revenue And Forecasts to 2027 (USD Million)
Table 84. Middle East and Africa: Vaccines Market, By Route Of Administration - Revenue And Forecasts to 2027 (USD Million)
Table 85. Middle East and Africa: Vaccines Market, By Patient Type - Revenue And Forecasts to 2027 (USD Million)
Table 86. UAE Vaccines Market, By Technology - Revenue And Forecast to 2027 (USD Million)
Table 87. UAE: Vaccines Market, By Disease Indication - Revenue And Forecasts to 2027 (USD Million)
Table 88. UAE: Vaccines Market, By Hepatitis - Revenue And Forecasts to 2027 (USD Million)
Table 89. UAE: Vaccines Market, By Route Of Administration - Revenue And Forecasts to 2027 (USD Million)
Table 90. UAE: Vaccines Market, By Patient Type - Revenue And Forecasts to 2027 (USD Million)
Table 91. Saudi Arabia Vaccines Market, By Technology - Revenue And Forecast to 2027 (USD Million)
Table 92. Saudi Arabia: Vaccines Market, By Disease Indication - Revenue And Forecasts to 2027 (USD Million)
Table 93. Saudi Arabia: Vaccines Market, By Hepatitis - Revenue And Forecasts to 2027 (USD Million)
Table 94. Saudi Arabia: Vaccines Market, By Route Of Administration - Revenue And Forecasts to 2027 (USD Million)
Table 95. Saudi Arabia: Vaccines Market, By Patient Type - Revenue And Forecasts to 2027 (USD Million)
Table 96. South Africa Vaccines Market, By Technology - Revenue And Forecast to 2027 (USD Million)
Table 97. South Africa: Vaccines Market, By Disease Indication - Revenue And Forecasts to 2027 (USD Million)
Table 98. South Africa: Vaccines Market, By Hepatitis - Revenue And Forecasts to 2027 (USD Million)
Table 99. South Africa: Vaccines Market, By Route Of Administration - Revenue And Forecasts to 2027 (USD Million)
Table 100. South Africa: Vaccines Market, By Patient Type - Revenue And Forecasts to 2027 (USD Million)
Table 101. South and Central America Vaccines Market, By Technology - Revenue And Forecast to 2027 (USD Million)
Table 102. South and Central America: Vaccines Market, By Disease Indication - Revenue And Forecasts to 2027 (USD Million)
Table 103. South and Central America: Vaccines Market, By Hepatitis - Revenue And Forecasts to 2027 (USD Million)
Table 104. South and Central America: Vaccines Market, By Route Of Administration - Revenue And Forecasts to 2027 (USD Million)
Table 105. South and Central America: Vaccines Market, By Patient Type - Revenue And Forecasts to 2027 (USD Million)
Table 106. Brazil Vaccines Market, By Technology - Revenue And Forecast to 2027 (USD Million)
Table 107. Brazil: Vaccines Market, By Disease Indication - Revenue And Forecasts to 2027 (USD Million)
Table 108. Brazil: Vaccines Market, By Hepatitis - Revenue And Forecasts to 2027 (USD Million)
Table 109. Brazil: Vaccines Market, By Route Of Administration - Revenue And Forecasts to 2027 (USD Million)
Table 110. Brazil: Vaccines Market, By Patient Type - Revenue And Forecasts to 2027 (USD Million)
Table 111. Argentina Vaccines Market, By Technology - Revenue And Forecast to 2027 (USD Million)
Table 112. Argentina: Vaccines Market, By Disease Indication - Revenue And Forecasts to 2027 (USD Million)
Table 113. Argentina: Vaccines Market, By Hepatitis - Revenue And Forecasts to 2027 (USD Million)
Table 114. Argentina: Vaccines Market, By Route Of Administration - Revenue And Forecasts to 2027 (USD Million)
Table 115. Argentina: Vaccines Market, By Patient Type - Revenue And Forecasts to 2027 (USD Million)
Table 116. Organic Developments Done By Companies
Table 117. Inorganic developments done by Companies
Table 118. Glossary of Terms, vaccines marketList of Figures
Figure 1. Vaccines Market Segmentation
Figure 2. Vaccines Segmentation, by Region
Figure 3. Vaccines Market Overview
Figure 4. Conjugate VAccines technology Segment Held Largest Share of vaccines Market
Figure 5. APAC to show Significant Growth during Forecast Period
Figure 6. Vaccines Market, by Geography (US$ Million)
Figure 7. Global Vaccines Market - Leading Country Markets (US$ Million)
Figure 8. Global Vaccines Market, Industry Landscape
Figure 9. North America PEST Analysis
Figure 10. Europe PEST Analysis
Figure 11. Asia pacific PEST Analysis
Figure 12. Middle East & Africa PEST Analysis
Figure 13. South and central america PEST Analysis
Figure 14. vaccines market impact analysis of driver and restraints
Figure 15. global Vaccines market - Revenue Forecasts and Analysis -2019- 2027
Figure 16. global Vaccines market - by geography Forecasts and Analysis - 2019- 2027
Figure 17. Vaccines Market Share, Technology, 2019 and 2027 (%)
Figure 18. Recombinant Vaccinesinant Vaccines: Vaccines Market- Revenue and Forecasts to 2027 (US$ Million)
Figure 19. Conjugate Vaccines: Vaccines Market- Revenue and Forecasts to 2027 (US$ Million)
Figure 20. Live Attenuated Vaccines Attenuated Vaccines: Vaccines Market - Revenue and Forecasts to 2027 (US$ Million)
Figure 21. Inactivated and Subunit Vaccines Vaccines: Vaccines Market- Revenue and Forecasts to 2027 (US$ Million)
Figure 22. Toxoid Vaccines Vaccines: Vaccines Market- Revenue and Forecasts to 2027 (US$ Million)
Figure 23. Disease Indication MARKET Analysis and Forecasts 2019 and 2027 (%)
Figure 24. DTP (Diphtheria, Tetanus, and Pertussis): Vaccines Market- Revenue and Forecasts to 2027 (US$ Million)
Figure 25. Influenza: Vaccines Market- Revenue and Forecasts to 2027 (US$ Million)
Figure 26. Dengue: Vaccines Market - Revenue and Forecasts to 2027 (US$ Million)
Figure 27. Cytomegalovirus (CMV): Vaccines Market - Revenue and Forecasts to 2027 (US$ Million)
Figure 28. Hepatitis: Vaccines Market - Revenue and Forecasts to 2027 (US$ Million)
Figure 29. Hepatitis A: Hepatitis Market -Revenue and Forecasts to 2027 (US$ Million)
Figure 30. Hepatitis B: Vaccines Market -Revenue and Forecasts to 2027 (US$ Million)
Figure 31. Respiratory Syncytial Virus (RSV): Vaccines Market - Revenue and Forecasts to 2027 (US$ Million)
Figure 32. Other Diseases: Vaccines Market - Revenue and Forecasts to 2027 (US$ Million)
Figure 33. route of administration MARKET Analysis and Forecasts 2019 and 2027 (%)
Figure 34. Oral: Vaccines Market - Revenue and Forecasts to 2027 (US$ Million)
Figure 35. Injectable: Vaccines Market - Revenue and Forecasts to 2027 (US$ Million)
Figure 36. Other Routes of Administration: Vaccines Market - Revenue and Forecasts to 2027 (US$ Million)
Figure 37. patient type MARKET Analysis and Forecasts 2019 and 2027 (%)
Figure 38. Pediatric: Vaccines Market - Revenue and Forecasts to 2027 (US$ Million)
Figure 39. Adults: Vaccines Market - Revenue and Forecasts to 2027 (US$ Million)
Figure 40. North America: Vaccines Market, by Country (2019) (usD Million)
Figure 41. North America Vaccine Market Revenue and Forecasts to 2027 (US$ Million)
Figure 42. North America: Vaccines Market, by Country, 2019& 2027 (%)
Figure 43. US Vaccine Market Revenue and Forecasts to 2027 (US$ Million)
Figure 44. Canada Vaccine Market Revenue and Forecasts to 2027 (US$ Million)
Figure 45. Mexico Vaccine Market Revenue and Forecasts to 2027 (US$ Million)
Figure 46. Europe Vaccine Market Revenue and Forecasts to 2027 (US$ Million)
Figure 47. Europe: Vaccines Market, by Country, 2019 & 2027 (%)
Figure 48. Germany Vaccine Market Revenue and Forecasts to 2027 (US$ Million)
Figure 49. UK Vaccine Market Revenue and Forecasts to 2027 (US$ Million)
Figure 50. France Vaccine Market Revenue and Forecasts to 2027 (US$ Million)
Figure 51. Italy Vaccine Market Revenue and Forecasts to 2027 (US$ Million)
Figure 52. Spain Vaccine Market Revenue and Forecasts to 2027 (US$ Million)
Figure 53. Asia Pacific Vaccines market revenue Overview, by Country (2019) (us $ mn)
Figure 54. Asia Pacific Vaccine Market Revenue and Forecasts to 2027 (US$ Million)
Figure 55. Asia Pacific: Vaccines Market, by Country, 2018 & 2027 (%)
Figure 56. China Vaccine Market Revenue and Forecasts to 2027 (US$ Million)
Figure 57. Japan Vaccine Market Revenue and Forecasts to 2027 (US$ Million)
Figure 58. India Vaccine Market Revenue and Forecasts to 2027 (US$ Million)
Figure 59. Australia Vaccine Market Revenue and Forecasts to 2027 (US$ Million)
Figure 60. South Korea Vaccine Market Revenue and Forecasts to 2027 (US$ Million)
Figure 61. Middle East & Africa Vaccines market REVENUE, by Country, 2019 (US$ MN)
Figure 62. Middle East and Africa Vaccine Market Revenue and Forecasts to 2027 (US$ Million)
Figure 63. Middle East & Africa: Vaccines Market, by Country, 2019 & 2027 (%)
Figure 64. UAE Vaccine Market Revenue and Forecasts to 2027 (US$ Million)
Figure 65. Saudi Arabia Vaccine Market Revenue and Forecasts to 2027 (US$ Million)
Figure 66. South Africa Vaccine Market Revenue and Forecasts to 2027 (US$ Million)
Figure 67. South and Central America Vaccines market REVENUE, by Country, 2019 (US$ MN)
Figure 68. South and Central America Vaccine Market Revenue and Forecasts to 2027 (US$ Million)
Figure 69. South and Central America: Vaccines Market, by Country, 2019 and 2027 (%)
Figure 70. Brazil Vaccine Market Revenue and Forecasts to 2027 (US$ Million)
Figure 71. Argentina Vaccine Market Revenue and Forecasts to 2027 (US$ Million)
Figure 72. Impact of COVID-19 Pandemic Vaccines Market in North American Countries
Figure 73. Impact of COVID-19 Pandemic Vaccines Market in European Countries
Figure 74. Impact of COVID-19 Pandemic Vaccines Market in Asia Pacific Countries
Figure 75. Impact of COVID-19 Pandemic Vaccines Market in Rest of World Countries
Figure 76. Growth Strategies done by the companies in the Market, (%)
Companies Mentioned
A selection of companies mentioned in this report includes:
- PFIZER INC
- GlaxoSmithKline plc.
- Merck & Co., Inc.
- Sanofi
- Johnson & Johnson Services, Inc
- Panacea Biotec Limited
- AstellasPharma Inc.
- NOVAVAX, INC.
- VBI Vaccines Inc.
- Bavarian Nordic
